SCM
RXDX
Silverarc Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,921
| Closed | -$1.49M | – | 90 |
|
|
2023
Q1 | $1.49M | Sell |
13,921
-36,079
| -72% | -$3.87M | 0.62% | 44 |
|
|
2022
Q4 | $5.5M | Buy |
+50,000
| New | +$5.5M | 1.57% | 19 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 87 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 81 |
|
|
2021
Q2 | – | Sell |
-15,000
| Closed | -$274K | – | 119 |
|
|
2021
Q1 | $274K | Buy |
+15,000
| New | +$274K | 0.15% | 79 |
|